Early infarct growth predicts long-term clinical outcome after thrombolysis

Journal of the Neurological Sciences

Volumn 316, Issue 1-2, 2012, Pages 99-103

  Cho, Kyung Hee ^a,b   Kwon, Sun U ^a   Lee, Deok Hee ^a   Shim, Woohyun ^c   Choi, Choonggon ^a   Kim, Sang Joon ^a   Suh, Dae Chul ^a   Kim, Jong S ^a   Kang, Dong Wha ^a  

^a University of Ulsan   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Acute stroke; Diffusion weighted imaging; MRI; Outcome; Thrombolysis

Indexed keywords

RECOMBINANT UROKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN INFARCTION SIZE; CEREBRAL ARTERY DISEASE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME;

AGED; CEREBRAL INFARCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84862789540     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.01.015     Document Type: Article

References (24)

1. K.C. Johnston, A.F. Connors Jr., D.P. Wagner, W.A. Knaus, X. Wang, and E.C. Haley Jr. A predictive risk model for outcomes of ischemic stroke Stroke 31 2 2000 448 455
2. V.N. Thijs, M.G. Lansberg, C. Beaulieu, M.P. Marks, M.E. Moseley, and G.W. Albers Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis Stroke 31 11 2000 2597 2602
3. K.O. Lovblad, A.E. Baird, G. Schlaug, A. Benfield, B. Siewert, and B. Voetsch Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome Ann Neurol 42 2 1997 164 170
4. A.J. Furlan, D. Eyding, G.W. Albers, Y. Al-Rawi, K.R. Lees, and H.A. Rowley Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset Stroke 37 5 2006 1227 1231
5. A.E. Baird, J. Dambrosia, S. Janket, Q. Eichbaum, C. Chaves, and B. Silver A three-item scale for the early prediction of stroke recovery Lancet 357 9274 2001 2095 2099
6. P.J. Hand, J.M. Wardlaw, C.S. Rivers, P.A. Armitage, M.E. Bastin, and R.I. Lindley MR diffusion-weighted imaging and outcome prediction after ischemic stroke Neurology 66 8 2006 1159 1163
7. J.M. Wardlaw, S.L. Keir, M.E. Bastin, P.A. Armitage, and A.K. Rana Is diffusion imaging appearance an independent predictor of outcome after ischemic stroke? Neurology 59 9 2002 1381 1387
8. S. Warach, L.C. Pettigrew, J.F. Dashe, P. Pullicino, D.M. Lefkowitz, and L. Sabounjian Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators Ann Neurol 48 5 2000 713 722
9. W. Hacke, G. Albers, Y. Al-Rawi, J. Bogousslavsky, A. Davalos, and M. Eliasziw The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase Stroke 36 1 2005 66 73
10. S. Warach, D. Kaufman, D. Chiu, T. Devlin, M. Luby, and A. Rashid Effect of the Glycine Antagonist Gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy Cerebrovasc Dis 21 1-2 2006 106 111
11. J.G. Merino, L.L. Latour, J.W. Todd, M. Luby, P.D. Schellinger, and D.W. Kang Lesion volume change after treatment with tissue plasminogen activator can discriminate clinical responders from nonresponders Stroke 38 11 2007 2919 2923
12. A.H. Cho, S.I. Sohn, M.K. Han, D.H. Lee, J.S. Kim, and C.G. Choi Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report Cerebrovasc Dis 25 6 2008 572 579
13. C.A. Labarrere, D. Pitts, D.R. Nelson, and W.P. Faulk Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients N Engl J Med 333 17 1995 1111 1116
14. C.A. Lewandowski, M. Frankel, T.A. Tomsick, J. Broderick, J. Frey, and W. Clark Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial Stroke 30 12 1999 2598 2605
15. S.H. Yoo, S.U. Kwon, D.H. Lee, S.J. Kim, J.S. Kim, and D.W. Kang Comparison between MRI screening and CT-plus-MRI screening for thrombolysis within 3 h of ischemic stroke J Neurol Sci 294 1-2 2010 119 123
16. C. Berger, M. Fiorelli, T. Steiner, W.R. Schabitz, L. Bozzao, and E. Bluhmki Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 32 6 2001 1330 1335
17. H.P. Adams Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, and D.L. Gordon Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment Stroke 24 1 1993 35 41
18. W.D. Freeman, K.M. Barrett, M.L. Freeman, M. Johnson, G. Divertie, and A.O. Rossetti Predictors of awakening from postanoxic status epilepticus after therapeutic hypothermia Neurology 73 18 2009 1512 author reply - 3.
19. M. Luby, J.L. Bykowski, P.D. Schellinger, J.G. Merino, and S. Warach Intra- and interrater reliability of ischemic lesion volume measurements on diffusion-weighted, mean transit time and fluid-attenuated inversion recovery MRI Stroke 37 12 2006 2951 2956
20. R. Delgado-Mederos, A. Rovira, J. Alvarez-Sabin, M. Ribo, J. Munuera, and M. Rubiera Speed of tPA-induced clot lysis predicts DWI lesion evolution in acute stroke Stroke 38 3 2007 955 960
21. P.D. Schellinger, O. Jansen, J.B. Fiebach, S. Heiland, T. Steiner, and S. Schwab Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI Stroke 31 6 2000 1318 1328
22. S.M. Davis, G.A. Donnan, M.W. Parsons, C. Levi, K.S. Butcher, and A. Peeters Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial Lancet Neurol 7 4 2008 299 309
23. M.R. Gaudinski, E.C. Henning, A. Miracle, M. Luby, S. Warach, and L.L. Latour Establishing final infarct volume: stroke lesion evolution past 30 days is insignificant Stroke 39 10 2008 2765 2768
24. K.M. Barrett, Y.H. Ding, D.P. Wagner, D.F. Kallmes, and K.C. Johnston Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy Stroke 40 7 2009 2422 2427